Video & Publications | FUJIFILM Wako Chemicals Europe

Videos & Publications

Diagnostic Reagents and Tests

β-Glucan Test

With the introduction of the β-Glucan test for determining (1→3)-β-D-glucan in serum or plasma, FUJIFILM Wako presents a single test assay which provides quick and easy results for the early detection of invasive fungal infections.

Short video product introduction

Step by step video instruction for the FUJIFILM Wako β-Glucan test

Learn more about the diagnostic performance and clinical applications of the β-glucan test in the following presentations given during sponsored diagnostic symposia at "Trends in Medical Mycology (TIMM)" in recent years.

2023

The presentation by Dr. Teresa Peláez, Biosanitary Research Institute of the Principality of Asturias, Spain: "Optimizing the diagnosis of intra-abdominal candidiasis: Combination of BDG and Candida PCR"

2021

The presentation by Prof. Maurizio Sanguinetti, Director of the Institute of Microbiology, Catholic University of the Sacred Heart, Rome, Italy: "New developments in the established panfungal marker (1,3)-β-D-Glucan"

The presentation by Dr. Breda Lynch, Mater Misericordiae University Hospital Dublin, Ireland: “Implementing BDG testing: One test – Multiple benefits”

Leading European experts in the field of clinical diagnostic mycology have gained experience with the system for measuring of β-glucan in single test format. Follow the three links below to interviews on the platform healthcare-in-europe.com (HiE):

An interview published in European Hospital with Prof. Katrien Lagrou, Head of the Department of Microbiology, Immunology and Transplantation at the University of Leuven, Belgium: “Better detection and diagnosis of fungal infections”

An interview published in European Hospital with Prof. Oliver Kurzai, Chair of the Department of Hygiene and Microbiology at the University of Würzburg, Germany: “New test for early fungal infection detection”

An interview published in LABBook with Prof. Maurizio Sanguinetti, Director of the Institute of Microbiology, Catholic University of the Sacred Heart, Rome, Italy: "One test winning over a run of 10 New β-Glucan test delivers rapid results"

Dichtl K. et al., Evaluation of a Turbidimetric β-D-Glucan Test for Detection of Pneumocystis jirovecii Pneumonia. J. Clin. Microbiol., 56, e00286-18 (2018)

Dichtl K. et al., Serological biomarkers of candidemia: a retrospective evaluation of three assays. Infection, 47, 217–224 (2019)

Mercier T. et al., Beta-D-Glucan for Diagnosing Pneumocystis Pneumonia: a Direct Comparison between the Wako β-Glucan Assay and the Fungitell Assay. J. Clin. Microbiol., 57,.e00322-19 (2019)

De Carolis et al., Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases. PLos One., 15, e0236095 (2020)

Mercier T. et al., Prospective Evaluation of the Turbidimetric β-D-Glucan Assay and 2 Lateral Flow Assays on Serum in Invasive Aspergillosis. Clinical Infectious Diseases, ciaa295 (2020)

Cento V. et al., Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study. Mycoses, DOI: 10.1111/myc.13170 (2020)

Dichtl K. et al., Comparison of β-D-Glucan and Galactomannan in Serum for Detection of Invasive Aspergillosis: Retrospective Analysis with Focus on Early Diagnosis. J. Fungi 2020, 6(4), 253 (2020)

> to the product pages and information for Health Care Providers

HCC Biomarkers

FUJIFILM Wako offers the in vitro diagnostic blood tests AFP-L3 and DCP for the risk assessment of developing Hepatocellular Carcinoma (HCC) on the µTASWako™ platform.

Learn more about the clinical significance and possible applications of the tests in the following presentations, which were given during the "Product Theater" at the APASL (Asian Pacific Association for the Study of the Liver) congress 2021.

The presentation by Prof. Masatoshi Kudo, Kindai University Hospital, Japan: "Surveillance of HCC in high risk patients: Role of PIVKA II and AFP-L3"

The presentation by Dr. Hidenori Toyoda, Ogaki Municipal Hospital, Japan: "Use of µTASWako i30 in surveillance of HCC"

AASLD 2013 Washington, Toyoda H. et al., Diagnosis of Hepatocellular Carcinoma Using a GALAD Model by Objective Clinical and Serological Factors

Best J. et al., The GALAD Scoring Algorithm Based on AFP, AFP-L3 and DCP Significantly Improves Detection of BCLC Early Stage Hepatocellular Carcinoma, German Journal of Gastroenterology 2016, 54: 1296-1305

Chang W. W. P. et al., Microfluidic Immunoassays on Polymeric Microships, IVD Technology Magazine, Spring 2010, p. 6-11

EASL 2015 Vienna, Berhane S. et al., The GALAD Score for the Serological Detection of Hepatocellular Carcinoma: International Validation adn Assessment of the Influence of Tumour Size and Aetiology on Model Utility

Falk Workshop 2012 Hamburg, Bettinger D. et al., Tumor Markers for HCC-Screening in Patients with Liver Cirrhosis and Hepatic Inflammation

EASL and EORTC, EASL-EORTC Clinical Practice Guidelines: Management of Hepatocellular Carcinoma, Journal of Hepatology, April 2012, 56 (4): 908-943

Ertle J. et al., A Combination of α-fetoprotein and Des-γ-carboxy Prothrombin is Superior in Detection of Hepatocellular Carcinoma, Digestion 2013, 87 (2): 121-31

Ohmura et al., Annual Meeting of Japanese Society of Laboratory Medicine, 2009

Toyoda H. et al., Clinical Utility of Highly Sensitive Lens Culinaris Agglutinin-reactive alpha-fetoprotein in Hepatocellular Carcinoma Patients with alpha-fetoprotein <20 ng/ml, Cancer Science, May 2011, 102 (5): 1025-1031

Makuuchi M. et al., Development of Evidence-based Clinical Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma in Japan, Hepatology Research, January 2008, 38(1): 37-51